From: Cancer incidence and mortality trends in Australian adolescents and young adults, 1982–2007
Mortality rates, Males | Mortality rates, Females | |||||
---|---|---|---|---|---|---|
Trend 1 | Trend 1 | Trend 2 | ||||
Diagnostic Groups | Period | APC 95% CI | Period | APC 95% CI | Period | APC 95% CI |
All Tumours | 82 − 05 | −2.6* (-3.3; -2.0) | 82 − 05 | −4.6* (-5.1; -4.1) | ||
Leukaemia | 82 − 05 | −3.6* (-5.9; -1.2) | 82 − 05 | −3.8* (-6.1; -1.5) | ||
Myeloid | 82 − 05 | −5.6* (-8.0; -3.1) | 82 − 05 | −5.0* (-8.3; -1.6) | ||
Lymphocytic | 82 − 05 | 1.6 (-1.5; 4.8) | 82 − 05 | −2.2 (-5.3; -0.9) | ||
Lymphoma a | 82 − 05 | −5.4* (-7.4; -3.4) | 82 − 05 | −4.9* (-7.7; -2.0) | ||
NHL | 82 − 05 | −4.8* (-7.1; -2.5) | 82 − 05 | −4.5* (-7.3; -1.7) | ||
CNS | 82 − 05 | −3.1* (-4.8; -1.4) | 82 − 05 | −4.6* (-6.9; -2.1) | ||
Bone | 82 − 05 | −1.8 (-5.0; 1.5) | 82 − 05 | 4.3* (-0.4; 9.2) | ||
Soft Tissue | 82 − 05 | −4.7* (-7.6; 1.8) | 82 − 05 | −3.7* (-7.0; -0.2) | ||
Germ Cell a | 82 − 05 | −8.2* (-10.5;-5.8) | 82 − 05 | −1.3 (-6.1; 3.6) | ||
Gonadal | 82 − 05 | −7.7* (-10.3;-5.1) | ||||
Melanoma | 82 − 05 | −5.5* (-7.5; -3.4) | 82 − 05 | −10.9* (-13.5;-8.2) | ||
Carcinoma a | 82 − 05 | −2.4* (-3.4; -1.5) | 82 − 96 | −3.0* (-4.2; -1.7) | 96 − 05 | −8.2* (-10.7; -5.5) |
Breast | na | na | 82 − 96 | −3.0* (-4.2; -1.3) | 96 − 05 | −14.4* (-18.4; -9.9) |
Colon & Rectum | 82 − 05 | −2.1* (-4.0; -0.1) | 82 − 05 | −2.3* (-3.7;-0.8) | ||
Ovary | na | na | 82 − 05 | −2.6 (-5.5; -0.5) | ||
Lung | 82 − 05 | −2.8* (-5.2; -0.3) | 82 − 05 | −0.9* (-1.3; 3.1) | ||
Cervix Uteri | na | na | 82 − 05 | −6.8* (-8.2; -5.3) | ||
Lip & Oral Cavity | 82 − 05 | −3.4* (-5.5; -1.3) |